Isolated bacteria and susceptibilities to antimicrobial agents in biliary infections

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 686-690

  Mukaiya, Mitsuhiro ^a   Hirata, Koichi ^a   Katsuramaki, Tadashi ^a   Kihara, Chikashi ^a   Kimura, Yasutoshi ^a   Yamaguchi, Koji ^a   Furuhata, Tomohisa ^a   Hata, Fumitake ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial susceptibility tests; Biliary infection; Drug resistant bacteria

Indexed keywords

AMIKACIN; AMPICILLIN; CARUMONAM; CEFMENOXIME; CEFOTIAM; CEFOZOPRAN; CEFSULODIN; CLINDAMYCIN; HABEKACIN; IMIPENEM; MEROPENEM; PIPERACILLIN; SULPERAZON; TEICOPLANIN; VANCOMYCIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BILIARY TRACT INFECTION; ENTEROBACTER; ESCHERICHIA COLI; GASTROINTESTINAL SURGERY; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM NEGATIVE ANAEROBIC BACTERIA; GRAM POSITIVE AEROBIC BACTERIUM; GRAM POSITIVE ANAEROBIC BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; CHOLANGITIS; CHOLECYSTITIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SURGICAL WOUND INFECTION;

EID: 20644447132     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Japan Society of Chemotherapy, Committee of Clinical Evaluation Methods for Antibiotics, Committee on Prophylactic Antibiotics for Surgery: Guideline for the Assessment of the Therapeutic Efficacy of Antibiotics for Postoperative Infections in Japan (1997). J Infect Chemother 1998; 4(4):151-157.
2. Shimada K, Inamatsu T, Yamashiro M: Anaerobic bacteria in biliary disease in elderly patients. J Infect Dis 1977; 135(5):850-854.
3. Bjorvatn B: Cholecystitis-etiology and treatment-microbiological aspects. Scand J Gastroenterol Suppl 1984; 90:65-70.
4. Maluenda F, Csendes A, Burdiles P, Diaz J: Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 1989; 36(3):132-135.
5. Hansen DS, Gottschau A, Kolmos HJ: Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control. J Hosp Infect 1998; 38(2):119-132.
6. Iwai S, Sato T, Kunimatsu M, Tanaka H, Kato K, Akutsu M, Tanaka T: Hospital acquired infection in surgical field and its countermeasure present situation of anaerobes, P. aeruginosa and MRSA infection. Nippon Geka Gakkai Zasshi 1992; 93(9):906-909. (In Japanese)
7. Tanimura H, Tsunoda T, Ishimoto K, Hirokawa F, Sakaguchi S: Severe surgical infection with no information in terms of bacteria. Nippon Geka Gakkai Zasshi 1996; 97(12):1066-1071. (In Japanese)
8. Brook I, Frazier EH: Aerobic and anaerobic infection associated with malignancy. Support Care Cancer 1998; 6(2):125-131.
9. Marne C, Pallares R, Martin R, Sitges-Serra A: Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol 1986; 5(1):35-39.
10. DiPiro JT, Edmiston CE Jr, Bohnen JM: Pharmacodynamics of antimicrobial therapy in surgery. Am J Surg 1996; 171(6):615-622.
11. Odenholt I: Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int J Antimicrob Agents 2001; 17(1):1-8.
12. Shinagawa N, Takeda S, Oohira S, et al: Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections. Jpn J Antibiot 1997; 50(11):862-870. (In Japanese)
13. Gunderson BW, Ross GH, Ibrahim KH, et al: What do we really know about antibiotic pharmacodynamics? Pharmacotherapy 2001; 21(11 Pt 2):302S-318S.